机器学习模型预测了在患有炎症性肠病 (复发性CDI-IBD) 的患者中复发的Clostridioides difficile感染
Raseen Tariq1, Ankita Sethi2, Shivaram Arunachalam2
1Mayo Clinic, Rochester, Minnesota & Virginia Commonwealth University, Richmond, VA.
The American journal of gastroenterology
|January 21, 2026
概括
一种新的机器学习模型RecurCDI-IBD可以预测炎症性肠病 (IBD) 患者的复发性Clostridioides difficile感染 (CDI). 该工具有助于识别高风险个体,以提供有针对性的干预措施和改善结果.
科学领域:
- 医疗信息学 医疗信息学
- 医疗保健中的机器学习
- 胃肠病学 胃肠病学
背景情况:
- 艰难菌感染 (CDI) 对炎症性肠病 (IBD) 患者构成重大挑战,往往导致高复发率和并发症.
- 准确预测复发性CDI (rCDI) 对于及时干预和改善这种脆弱人群的患者管理至关重要.
研究的目的:
- 开发和验证一种监督机器学习模型,称为RecurCDI-IBD,用于预测成人IBD患者的rCDI.
- 确定与IBD患者的rCDI风险相关的关键临床和人口因素.
主要方法:
- 一种渐变增强机 (XGBoost) 模型使用2013年至2021年期间被诊断为CDI的成年IBD患者的数据进行了训练.
- 功能工程结合了人口统计,临床 (IBD亚型,药物,并发症) 和实验室数据,以预测在最初发作后60天内的rCDI.
主要成果:
- RecurCDI-IBD模型表现出强大的预测性能,准确度为80.05%,曲线下的面积为0.88.
- 显著的rCDI预测因素包括IBD亚型,性别,使用类固醇和抗TNF药物,以及慢性肺和病等并发症.
结论:
- 复发性CDI-IBD模型有效地识别出具有复发性CDI风险较高的IBD患者,显示出平衡的精度和回忆.
- 这些数据驱动的见解可以提高临床风险评估,尽管建议在更大,更多样化的队列中进一步验证.
相关概念视频
01:30Inflammatory Bowel Disease II: Crohn's Disease
984
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
984
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
926
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
926
01:21Inflammatory Bowel Disease V: Surgical Management
461
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
461
01:29Inflammatory Bowel Disease IV: Pharmacological Management
548
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
548
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
651
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
651
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
443
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
443